(Total Views: 686)
Posted On: 10/30/2020 1:26:39 PM
Post# of 156317
I know this has already been discussed, just posting some links:
Wall Street Journal
Trial of Regeneron’s Covid-19 Antibody Drug Is Halted in Sickest Hospital Patients
https://news.google.com/articles/CAIiEFdhTyM-...id=US%3Aen
MarketWatch
Regeneron says IDMC recommends halt of some REGN-COV2 trial enrollment for safety risks
https://www.marketwatch.com/story/regeneron-s...2020-10-30
Fierce Biotech
Regeneron hit by 'safety signal' for COVID-19 cocktail as data board tells pharma to stop enrolling sicker patients
https://www.fiercebiotech.com/biotech/regener...ma-to-stop
Wall Street Journal
Trial of Regeneron’s Covid-19 Antibody Drug Is Halted in Sickest Hospital Patients
https://news.google.com/articles/CAIiEFdhTyM-...id=US%3Aen
MarketWatch
Regeneron says IDMC recommends halt of some REGN-COV2 trial enrollment for safety risks
https://www.marketwatch.com/story/regeneron-s...2020-10-30
Fierce Biotech
Regeneron hit by 'safety signal' for COVID-19 cocktail as data board tells pharma to stop enrolling sicker patients
https://www.fiercebiotech.com/biotech/regener...ma-to-stop
(0)
(0)
